Artificial Intelligence Designs a New Drug: The First AI-Discovered Medication
Introduction Pharmaceutical R&D is expensive, risky, and time-consuming, sometimes taking over a decade from target identification to market approval. But artificial intelligence (AI) is transforming how scientists approach this process—sho...
Read MorePolio Drug: Experimental Antiviral to Treat Polio Infections Under Study
Introduction Polio, caused by the poliovirus, once paralyzed or killed hundreds of thousands globally. Thanks to mass vaccination, polio cases have fallen dramatically. Yet sporadic outbreaks persist, often in regions with incomplete immunization...
Read MoreNew Tuberculosis Vaccine Trials: A Century Wait for a Better TB Shot
Introduction Tuberculosis (TB) remains one of the oldest yet deadliest infectious diseases, claiming over a million lives each year, especially in low-resource regions. Although the BCG (Bacillus Calmette–Guérin) vaccine has been around for...
Read MoreFirst Needle-Free Vaccine Patch: Could Painless Patches Replace Needles?
Introduction Despite the undeniable success of vaccines in controlling infectious diseases, many still dread the needle stick and potential side effects of traditional injections. But a new frontier in immunization—needle-free vaccine patchesâ€...
Read MoreEngineered T-Cells vs HIV: Trials Begin for Immune Cell Therapy in HIV
Introduction For decades, antiretroviral therapy (ART) has managed HIV by suppressing viral replication, improving patients’ health, and reducing transmission. However, ART isn’t a cure; strict adherence and potential side effects remain chal...
Read More